A
Axsome Therapeutics, Inc. (AXSM)
NGM – Real Time Price. Currency in USD
241.67
+4.34 (1.83%)
At close: Jun 26, 2026, 4:00 PM EDT
246.64
+4.97 (2.06%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
241.67
+4.34 (1.83%)
At close: Jun 26, 2026, 4:00 PM EDT
246.64
+4.97 (2.06%)
After-hours: Jun 26, 2026, 7:11 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $305.1M significantly exceed its total debt $219.9M, ensuring strong financial flexibility
Total current assets $611.2M exceed Total current liabilities $439.2M, highlighting excellent liquidity
Debt-to-equity ratio (4.0) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-20.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$20.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.39 | 6.05 | 7.0 | |
| Quick ratio | 1.32 | 5.63 | 7.0 | |
| Debt to Equity | 4.03 | 0.30 | 2.0 | |
| Debt to Assets | 0.31 | 1.04 | 7.0 | |
| Interest coverage | -20.30 | -16.91 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 50M | 271M | 386M | 638M | 708M |
| Gross Profit | 39M | 238M | 344M | 582M | 647M |
| Operating Income | -176M | -183M | -252M | -169M | -177M |
| Net Income | -187M | -239M | -287M | -183M | -188M |
| EBITDA | -170M | -176M | -244M | -160M | -167M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 47.79 | 11.93 | 8.5 |
| Next quarter | 53.27 | 67.41 | 10 |
| Current year | 55.18 | 45.44 | 10 |
| Next year | 60.91 | 373.97 | 10 |
| Weighted average score | 9.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -2.44 | -125.99 | -124.99 | -11.19 | 1.0 |
| Y/Y | 57.42 | -8.62 | -3.27 | 52.37 | 5.5 |
| 3y average | 182.96 | -3.87 | 3.45 | 4.81 | 4.8 |
| 5y average | 509.38 | -16.36 | -9.48 | -6.37 | 3.3 |
| Weighted average score | 3.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Narrow | 4.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Medium | 6.0 |
| Network effect | None | 1.0 |
| Economies of scale | Medium | 5.0 |
| Weighted average score | 4.6 | |